AXSM
HEALTHCAREAxsome Therapeutics Inc
$222.63-0.43 (-0.19%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AXSM Today?
No stock-specific AI insight has been generated for AXSM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$96.09$234.29
$222.63
Fundamentals
Market Cap$11.5B
P/E Ratio—
EPS$-3.72
Dividend Yield—
Dividend / Share—
ROE-3.5%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume560K
Avg Volume (10D)—
Shares Outstanding51.5M
AXSM News
22 articles- Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market LeadersYahoo Finance·May 8, 2026
- 3 Stocks Poised to Disrupt the Healthcare Market by 2030Motley Fool·May 8, 2026
- Assessing Axsome Therapeutics (AXSM) Valuation After Strong Recent Share Price MomentumYahoo Finance·May 7, 2026
- Axsome Therapeutics Recognizes Mental Health MonthYahoo Finance·May 7, 2026
- How The Axsome Therapeutics (AXSM) Story Is Shifting After Auvelity And AXS 05 DevelopmentsYahoo Finance·May 7, 2026
- Is Axsome Therapeutics (AXSM) Starting To Look Fully Priced After Its 1-Year Share Price Surge?Yahoo Finance·May 6, 2026
- AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity SalesYahoo Finance·May 5, 2026
- 3 Overlooked Stocks Set to Soar in 2026Motley Fool·May 5, 2026
- Axsome Therapeutics to Participate in Upcoming Investor ConferencesYahoo Finance·May 5, 2026
- Axsome Continues Its Breakneck Pace On Solid First-Quarter SalesYahoo Finance·May 4, 2026
- Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy ZoneYahoo Finance·May 4, 2026
- Why Did Axsome Therapeutics Stock Hit Another Record High Today?Motley Fool·May 4, 2026
- Axsome Therapeutics, Inc. Q1 2026 Earnings Call SummaryMoby·May 4, 2026
- Axsome (AXSM) Q1 2026 Earnings Call TranscriptMotley Fool·May 4, 2026
- Axsome (AXSM) Q2 2025 Earnings TranscriptMotley Fool·May 4, 2026
- Axsome (AXSM) Q1 2025 Earnings Call TranscriptMotley Fool·May 4, 2026
- Axsome Therapeutics Q1 Earnings Call HighlightsMarketbeat·May 4, 2026
- Here's What Key Metrics Tell Us About Axsome (AXSM) Q1 EarningsYahoo Finance·May 4, 2026
- Axsome Therapeutics (AXSM) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 4, 2026
- Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·May 4, 2026
- Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4GlobeNewswire Inc.·Apr 8, 2026
- Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From NowThe Motley Fool·Mar 25, 2026
All 22 articles loaded
Price Data
Open$221.71
Previous Close$223.06
Day High$227.45
Day Low$220.85
52 Week High$234.29
52 Week Low$96.09
52-Week Range
$96.09$234.29
$222.63
Fundamentals
Market Cap$11.5B
P/E Ratio—
EPS$-3.72
Dividend Yield—
Dividend / Share—
ROE-3.5%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume560K
Avg Volume (10D)—
Shares Outstanding51.5M
About Axsome Therapeutics Inc
Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—